Manufacturer of Controlled Substances; Notice of Registration, 14843 [E8-5507]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices
Drug
Schedule
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
II
II
II
The company plans on manufacturing
the listed controlled substances in bulk
for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Cody
Laboratories to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Cody
Laboratories to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 10, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–5506 Filed 3–18–08; 8:45 am]
substances is consistent with the public
interest at this time. DEA has
investigated Cambridge Isotope Lab to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: March 10, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–5507 Filed 3–18–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated November 6, 2007
and published in the Federal Register
on November 16, 2007 (72 FR 64674),
Archimica, Inc., 2460 W. Bennett Street,
Springfield, Missouri 65807–1229, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug
Manufacturer of Controlled
Substances; Notice of Registration
jlentini on PROD1PC65 with NOTICES
Drug Enforcement Administration
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone Intermediate (9254) ...
By Notice dated November 6, 2007
and published in the Federal Register
on November 16, 2007 (72 FR 64677),
Cambridge Isotope Lab, 50 Frontage
Road, Andover, Massachusetts 01810,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Morphine (9300), a
basic class of controlled substance listed
in schedule II.
The company plans to utilize small
quantities of the listed controlled
substance in the preparation of
analytical standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambridge Isotope Lab to manufacture
the listed basic classes of controlled
VerDate Aug<31>2005
16:50 Mar 18, 2008
Jkt 214001
Schedule
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for research purposes, and sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Archimica, Inc. to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Archimica, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
14843
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 10, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–5508 Filed 3–18–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated November 20, 2007,
and published in the Federal Register
on November 30, 2007, (72 FR 67759–
67760), Norac Inc., 405 S. Motor
Avenue, P.O. Box 577, Azusa, California
91702–3232, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
class of controlled substance listed in
schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for formulation into the pharmaceutical
controlled substance Marinol.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Norac Inc. to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated Norac
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 10, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–5509 Filed 3–18–08; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 73, Number 54 (Wednesday, March 19, 2008)]
[Notices]
[Page 14843]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5507]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated November 6, 2007 and published in the Federal
Register on November 16, 2007 (72 FR 64677), Cambridge Isotope Lab, 50
Frontage Road, Andover, Massachusetts 01810, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of Morphine (9300), a basic class of controlled
substance listed in schedule II.
The company plans to utilize small quantities of the listed
controlled substance in the preparation of analytical standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cambridge Isotope Lab to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cambridge Isotope Lab to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substance listed.
Dated: March 10, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-5507 Filed 3-18-08; 8:45 am]
BILLING CODE 4410-09-P
